Drug Delivery Systems Market Size Worth US$ 363.82 Billion With CAGR of 6.10% from 2022 to 2030 | Exclusive Report by Growth Plus Reports

News provided by

Sep 30, 2022, 09:00 ET

NEW YORK, Sept. 30, 2022 /PRNewswire/ -- According to the latest report published by Growth Plus Reports, the global drug delivery systems market is expected to clock at US$ 363.82 billion by 2030 and to grow at a CAGR of 6.10% during the forecast period. The global drug delivery systems market is primarily driven by rising demand for biosimilars, and growing demand for vaccines and biologics. Additionally, the growing prevalence of chronic and infectious diseases and increasing adoption of novel drug delivery system are fueling the global drug delivery systems market.

Drug delivery systems help drug to reach site of action to achieve desired therapeutic effect with minimal time and safety. The route of administration is decided according to physical conditions and diseases, and to achieve maximum pharmacological index. Drug delivery systems are classified as targeted drug delivery systems, advanced drug delivery systems, conventional drug delivery systems, etc. Advanced drug delivery systems are focused on delivering drug to the active site by bypassing first pass effect which increases drug potency, therapeutic effect, and efficacy.

Download PDF Brochure of Drug Delivery Systems Market Size - COVID-19 Impact and Global Analysis with Strategic Developments at: https://growthplusreports.com/inquiry/request-sample/drug-delivery-systems-market/7824

Growth Drivers

Increasing demand for antivirals, vaccines and biologics are contributing to the growth of the global drug delivery system market. During the COVID-19 pandemic, many biotech and pharmaceutical companies collaborated with government for vaccine development. In September 2022, Bharat Biotech received approval for nasal COVID-19 vaccine from Central Drugs Standard Control Organization (CDSCO) under restricted use in emergency. Nasal drug delivery systems are mostly preferred due to its non-invasive and easy route of administration for children and adults.

The global drug delivery systems market has been analyzed from three different perspectives – Type, Application, and Region

Excerpts from 'by Type'

The global drug delivery systems market based on type has been segmented into:

Inhalation/Pulmonary Drug Delivery System
Transdermal Drug Delivery System
Transmucosal Drug Delivery System
Carrier-Based Drug Delivery System
Oral Drug Delivery System
Injectable Drug Delivery System
Other

Oral drug delivery systems are dominating the global drug delivery system market as it is the most preferred due to high compatibility for combination drugs, noninvasive delivery, and high compatibility. Additionally, convenience of self-administration, less cost of oral drugs, and availability of various diseases treatment are contributing to the prominent position of this segment. Injectable drug delivery systems are also expected to show exponential growth during the forecast period owing to increasing uptake of targeted drug delivery systems.

Excerpts From 'by Application'

The global drug delivery systems market based on the application has been segmented into:

Central Nervous System
Ophthalmology
Infections
Cardiovascular Diseases
Oncology
Urology
Diabetes
Others

Oncology segment is dominating the global drug delivery systems market owing to rising prevalence of cancer globally and increasing investment in research and development. According to the World Health Organization, in 2020 nearly 10 million people died because of cancer, and the most common cancers are lung cancer, breast cancer, and prostate cancers. Additionally growing regulatory approvals for novel cancer treatments and increasing government initiatives for novel drug approvals are contributing to the growth of the oncology segment.

Speak to our Analysts to Understand the Impact of COVID-19 on Your Business: https://growthplusreports.com/inquiry/speak-analyst/drug-delivery-systems-market/7824

Excerpts From 'by Region Segmentation'

The global drug delivery systems market has been segmented into:

North America
Europe
Asia Pacific
Rest of the World

The global drug delivery systems market is dominated by North America, followed by Asia Pacific. The large share of North America in the global market is attributed to high prevalence of chronic diseases and wide presence of key market players. Additionally, developed healthcare infrastructure, rapid adoption of novel drug delivery systems and technological advancement are contributing to the growth of North America drug delivery systems market.

Excerpts From 'Competitive Landscape'

The prominent players operating in the global drug delivery systems market

Baxter International Inc
Becton
Dickinson and Company
Bayer AG
F. Hoffmann-La Roche, Ltd
Gerresheimer AG
Johnson & Johnson Services, Inc
Novartis AG
Pfizer, Inc
Sibiono GeneTech Co. Ltd
uniQure N.V
West Pharmaceutical Services Inc

Table of Content

INTRODUCTION

Market Ecosystem
Timeline Under Consideration
Currency Used in the Report

RESEARCH METHODOLOGY

Research Approach
Data Collection Methodology
Data Sources

Secondary Sources
Primary Sources

Market Estimation Approach

Bottom Up
Top Down

Market Forecasting Model
Limitations and Assumptions

PREMIUM INSIGHTS

Current Market Trends (COVID-19 Perspective)
Key Players & Competitive Positioning (2021)

MARKET DYNAMICS

Drivers
Restraints/Challenges
Opportunities

GLOBAL DRUG DELIVERY SYSTEMS MARKET - ANALYSIS & FORECAST, BY TYPE

Inhalation/Pulmonary Drug Delivery System
Transdermal Drug Delivery System
Transmucosal Drug Delivery System
Carrier-based Drug Delivery System
Oral Drug Delivery System
Injection-based Drug Delivery System
Others

GLOBAL DRUG DELIVERY SYSTEMS MARKET - ANALYSIS & FORECAST, BY APPLICATION

Central Nervous System
Ophthalmology
Infections
Cardiovascular Diseases
Oncology
Urology
Diabetes
Others

VALUE PROPOSITIONS RELATED TO THE REPORT:

Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
Comprehensive quantitative and qualitative insights at segment and sub-segment level
Covid 19 impact trends and perspective
Granular insights at global/regional/country level
Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
Blanket coverage on competitive landscape
Winning imperatives
Exhaustive coverage on 'Strategic Developments' registered by leading players of the market

CUSTOMIZATION OPTIONS:

Distributor Landscape Assessment
Pricing Intelligence
Customer Base Assessment
Investment & Initiatives Analysis
'Business Profile' of Key Players

Directly Purchase Premium Copy of Drug Delivery Systems Market Growth Report (2022-2030) at:
https://growthplusreports.com/checkout?_token=isot7zu5VVnzHPwhjfJzucFkG0vkhsxiXTD8j6Gv&report_id=7824&license=Single

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.

Contact:
Manan Sethi Director, Market Insights
Email: [email protected]
Phone no: +91 96545 76783
Web: https://growthplusreports.com/
Follow Us: LinkedIn | Twitter

Logo: https://mma.prnewswire.com/media/1671244/Growth_Plus_Reports_Logo.jpg

SOURCE Growth Plus Reports